Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 55,813 shares at $108.07 ($6.0M) on 2014-08-25, disclosed to the SEC on 2014-08-27.
Open-market sale of $6.0M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.07 | 30,000 | $3.2M | 53.7% |
| 2 | $108.11 | 24,207 | $2.6M | 43.4% |
| 3 | $108.05 | 1,606 | $174K | 2.9% |
| Total | $108.09 avg | 55,813 | $6.0M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |